Stocks Overview

LAST PRICE
27.7100
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
27.7100/ 1
Ask / Lots
28.7500/ 10
Open / Previous Close
--- / 27.7100
Day Range
---
52 Week Range
Low 25.2000
High 31.6550
Volume
412
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Monday's close: 27.71
Time	Volume	RPRX
09:32 ET	7741	27.71
09:34 ET	2305	27.785
09:36 ET	600	27.75
09:38 ET	2400	27.745
09:39 ET	1400	27.725
09:41 ET	4321	27.755
09:43 ET	2100	27.75
09:45 ET	4098	27.67
09:48 ET	4140	27.715
09:50 ET	25244	27.75
09:52 ET	7747	27.76
09:54 ET	17898	27.7
09:56 ET	2723	27.7
09:57 ET	5679	27.7009
09:59 ET	3670	27.73
10:01 ET	7728	27.73
10:03 ET	2664	27.75
10:06 ET	18180	27.82
10:08 ET	4764	27.88
10:10 ET	1546	27.895
10:12 ET	10494	27.885
10:14 ET	4127	27.88
10:15 ET	1100	27.885
10:17 ET	3327	27.96
10:19 ET	5293	27.955
10:21 ET	2709	27.935
10:24 ET	7091	27.935
10:26 ET	4195	27.92
10:28 ET	9356	27.915
10:30 ET	8910	27.875
10:32 ET	4393	27.885
10:33 ET	4909	27.87
10:35 ET	7494	27.86
10:37 ET	2153	27.815
10:39 ET	2987	27.85
10:42 ET	4841	27.885
10:44 ET	4051	27.91
10:46 ET	2597	27.905
10:48 ET	1852	27.88
10:50 ET	2711	27.865
10:51 ET	1423	27.895
10:53 ET	7030	27.89
10:55 ET	300	27.885
10:57 ET	2109	27.9
11:00 ET	3201	27.875
11:02 ET	1931	27.85
11:04 ET	1100	27.8599
11:06 ET	5714	27.86
11:08 ET	1700	27.865
11:09 ET	2500	27.865
11:11 ET	4678	27.87
11:13 ET	500	27.88
11:15 ET	1318	27.88
11:18 ET	3900	27.875
11:20 ET	1931	27.855
11:22 ET	1844	27.83
11:24 ET	612	27.835
11:26 ET	1100	27.835
11:27 ET	2526	27.8376
11:29 ET	3120	27.84
11:31 ET	510	27.845
11:33 ET	3841	27.86
11:36 ET	1674	27.875
11:38 ET	2400	27.88
11:40 ET	4056	27.86
11:42 ET	1600	27.855
11:44 ET	2639	27.845
11:45 ET	2373	27.845
11:47 ET	5875	27.84
11:49 ET	3181	27.82
11:51 ET	9813	27.86
11:54 ET	1350	27.86
11:56 ET	2975	27.8657
11:58 ET	6157	27.885
12:00 ET	5929	27.87
12:02 ET	500	27.87
12:03 ET	3254	27.8574
12:05 ET	9181	27.825
12:07 ET	755	27.85
12:09 ET	2434	27.85
12:12 ET	200	27.855
12:14 ET	600	27.855
12:16 ET	2638	27.875
12:18 ET	24682	27.885
12:20 ET	2756	27.865
12:21 ET	1940	27.855
12:23 ET	663	27.855
12:25 ET	9057	27.855
12:27 ET	7656	27.83
12:30 ET	2359	27.785
12:32 ET	1100	27.795
12:34 ET	1803	27.785
12:36 ET	600	27.795
12:38 ET	5050	27.795
12:39 ET	1562	27.79
12:41 ET	1714	27.79
12:43 ET	5795	27.815
12:45 ET	3090	27.78
12:48 ET	2104	27.7992
12:50 ET	1600	27.78
12:52 ET	2200	27.795
12:54 ET	2000	27.8
12:56 ET	895	27.8
12:57 ET	1039	27.8099
12:59 ET	3931	27.8
01:01 ET	1368	27.795
01:03 ET	1161	27.795
01:06 ET	2725	27.79
01:08 ET	917	27.785
01:10 ET	523	27.785
01:12 ET	200	27.785
01:14 ET	1238	27.785
01:15 ET	1800	27.795
01:17 ET	2987	27.795
01:19 ET	2796	27.79
01:21 ET	6932	27.815
01:24 ET	1200	27.805
01:26 ET	300	27.81
01:28 ET	2319	27.815
01:30 ET	4176	27.82
01:32 ET	2125	27.81
01:33 ET	620	27.805
01:35 ET	300	27.81
01:37 ET	1145	27.795
01:39 ET	999	27.79
01:42 ET	306	27.7945
01:44 ET	660	27.8
01:46 ET	2120	27.805
01:48 ET	3606	27.785
01:50 ET	685	27.785
01:51 ET	200	27.79
01:53 ET	1187	27.785
01:55 ET	1746	27.795
01:57 ET	817	27.795
02:00 ET	3011	27.805
02:02 ET	3328	27.79
02:04 ET	613	27.795
02:06 ET	600	27.81
02:08 ET	1604	27.79
02:09 ET	1300	27.8
02:11 ET	300	27.805
02:13 ET	912	27.815
02:15 ET	782	27.815
02:18 ET	4420	27.805
02:20 ET	1777	27.7901
02:22 ET	300	27.795
02:24 ET	2684	27.775
02:26 ET	600	27.77
02:27 ET	5527	27.775
02:29 ET	2543	27.765
02:31 ET	5067	27.76
02:33 ET	2388	27.765
02:36 ET	3436	27.775
02:38 ET	3256	27.784
02:40 ET	2679	27.775
02:42 ET	3830	27.795
02:44 ET	925	27.795
02:45 ET	2007	27.8
02:47 ET	3212	27.805
02:49 ET	4483	27.825
02:51 ET	902	27.83
02:54 ET	3856	27.835
02:56 ET	2476	27.825
02:58 ET	800	27.825
03:00 ET	800	27.825
03:02 ET	3041	27.8111
03:03 ET	2806	27.84
03:05 ET	3235	27.85
03:07 ET	500	27.845
03:09 ET	4530	27.84
03:12 ET	450	27.845
03:14 ET	2150	27.855
03:16 ET	1600	27.855
03:18 ET	1015	27.865
03:20 ET	3514	27.855
03:21 ET	2248	27.845
03:23 ET	2933	27.85
03:25 ET	470	27.845
03:27 ET	3886	27.85
03:30 ET	2804	27.855
03:32 ET	4305	27.855
03:34 ET	1330	27.855
03:36 ET	2701	27.83
03:38 ET	3435	27.82
03:39 ET	1879	27.8
03:41 ET	3651	27.79
03:43 ET	3185	27.775
03:45 ET	8194	27.735
03:48 ET	7078	27.73
03:50 ET	11785	27.71
03:52 ET	7056	27.7
03:54 ET	10025	27.695
03:56 ET	23265	27.7318
03:57 ET	24131	27.695
03:59 ET	420657	27.71

Data delayed at least 15 minutes.

Sep 20, 2024
- DJ S&P 500 Futures Decline In Premarket Trading; FedEx, Frontline Lag, from 7:30AM ET on Friday Sep 20, 2024 by Dow Jones
  7:30AM ET on Friday Sep 20, 2024 by Dow Jones
Sep 18, 2024
- DJ S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
  7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 3, 2024
- Press Release: Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
- Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
- Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement, from 5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRPRX Royalty Pharma PLC	16.4B	18.4x	+1.83%
United StatesAMRX Amneal Pharmaceuticals Inc	2.6B	-13.6x	---
United StatesNDOI Endo Inc	2.0B	0.4x	---
United StatesCTLT Catalent Inc	10.9B	-10.5x	---
United StatesJAZZ Jazz Pharmaceuticals PLC	6.7B	18.7x	-3.53%
United StatesMCKPF Mallinckrodt PLC	1.6M	0.0x	---
As of 2024-09-25

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.

Contact Information

Headquarters: 110 East 59th StreetNEW YORK, NY, United States 10022
Phone: 212-883-0200
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Pablo Legorreta
Vice Chairman, Executive Vice President: Christopher Hite
Chief Financial Officer, Executive Vice President: Terrance Coyne
Executive Vice President - Investments and Chief Legal Officer: George Lloyd
Executive Vice President - Head of Human Capital: Molly Sawaya

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$16.4B
Revenue (TTM)	$2.2B
Shares Outstanding	593.5M
Dividend Yield	3.03%
Annual Dividend Rate	0.8400 USD
Ex-Dividend Date	08-16-24
Pay Date	09-13-24
Beta	0.46
EPS	$1.50
Book Value	$14.61
P/E Ratio	18.4x
Price/Sales (TTM)	7.3
Price/Cash Flow (TTM)	19.6x
Operating Margin	42.91%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Royalty Pharma PLC
NASDAQ:RPRXUnited States

Search Criteria

Charts

Recent News

Sep 20, 2024

DJ S&P 500 Futures Decline In Premarket Trading; FedEx, Frontline Lag, from 7:30AM ET on Friday Sep 20, 2024 by Dow Jones

Sep 18, 2024

DJ S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones

Sep 3, 2024

Press Release: Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones

Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement, from 5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar